Schering-Plough hires Schmitt for global PR post

Schering-Plough has hired Joy Schmitt from Genta Incorporated as director, global product communications and advocacy relations. Schmitt's duties in her new role include serving as the key relationship manager for HIV/AIDS and hepatitis C patient communities, along with PR and advocacy activities supporting the oncology franchise outside the U.S. Schmitt reports to vice president, global product communications and advocacy relations Mary-Frances Faraji. Before joining Genta, where she was director and head of public relations, she held communications posts at Agouron Pharmaceuticals (a Pfizer company) and Roche Laboratories.
Schmitt's appointment comes as the company is beefing up its global communications infrastructure. In December, the company appointed Gail Thornton, formerly of Pfizer Neuroscience, to head global communications.
You must be a registered member of MMM to post a comment.

A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.

Email Newsletters


Pharma continues to struggle with its image. Exhibit A is the public debate around the price of, and access to, new and innovative meds. As countless transformative technologies hit market, has industry done enough to anchor its permission to innovate? To provide a closer look at trends affecting trust over the past year, MM&M presents this e-book, "The 2015 Edelman Trust Barometer." Click here.